Frequently Asked Questions
The market is segmented based on , By Drug Classification (Prolia, Xgeva, and Others), End-Users (Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centres, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Denosumab Market size was valued at USD 2892.17 USD Million in 2022.
The Global Denosumab Market is projected to grow at a CAGR of 11.9% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
